With MAKO Surgical shares having taken a hit recently after a couple instances of lowering guidance, Motley Fool health care bureau chief Brenton Flynn took a look in a recent video at 2 key statistics to watch ahead of MAKO's third quarter earnings release: How many new sales of its robotic surgical systems did it make to hospitals this quarter, and how many procedures per month did these systems perform once they were installed? Now that the earnings have come out, Flynn breaks down his benchmarks for how the company needed to perform in these two vital areas, how it surpassed his expectations in one regard, and why he's still cautiously optimistic.
Motley Fool Returns
Discounted offers are only available to new members. Stock Advisor will renew at the then current list price. Stock Advisor list price is $199 per year.
Stock Advisor launched in February of 2002. Returns as of 10/18/2021.
Average returns of all recommendations since inception. Cost basis and return based on previous market day close.